ELIPHOS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eliphos, and when can generic versions of Eliphos launch?
Eliphos is a drug marketed by Cypress Pharm and is included in one NDA.
The generic ingredient in ELIPHOS is calcium acetate. There are two hundred and eighty-two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eliphos
A generic version of ELIPHOS was approved as calcium acetate by HIKMA on February 26th, 2008.
Summary for ELIPHOS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ELIPHOS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ELIPHOS
US Patents and Regulatory Information for ELIPHOS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cypress Pharm | ELIPHOS | calcium acetate | TABLET;ORAL | 078502-001 | Nov 25, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
